| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.09e-08 | 49 | 113 | 7 | GO:0140359 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC3 SLC29A3 ABCA4 SLC2A8 ATP13A1 SLC26A2 SLC26A4 ABCA10 ABCA9 SLC6A9 SLC39A12 SLC10A1 SLCO1C1 ABCA6 ABCA5 | 8.02e-08 | 477 | 113 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1E ABCC3 SLC29A3 ABCA4 SLC2A8 ATP13A1 SLC26A2 SLC26A4 BAX ABCA10 ABCA9 SLC6A9 SLC39A12 SLC10A1 SLCO1C1 ATP11B P2RX4 P2RX7 ABCA6 ABCA5 TRPM8 TRPV3 | 6.47e-07 | 1180 | 113 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.74e-06 | 196 | 113 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1E ABCC3 SLC29A3 ABCA4 SLC2A8 ATP13A1 SLC26A2 SLC26A4 BAX ABCA10 ABCA9 SLC6A9 SLC39A12 SLC10A1 SLCO1C1 ATP11B P2RX4 P2RX7 ABCA6 ABCA5 TRPM8 TRPV3 | 2.79e-06 | 1289 | 113 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.85e-06 | 109 | 113 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 6.94e-05 | 178 | 113 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | carnitine O-palmitoyltransferase activity | 1.89e-04 | 4 | 113 | 2 | GO:0004095 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 SLC2A8 SLC26A2 SLC26A4 SLC6A9 SLC39A12 SLC10A1 SLCO1C1 | 2.64e-04 | 293 | 113 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | O-palmitoyltransferase activity | 3.14e-04 | 5 | 113 | 2 | GO:0016416 | |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 4.69e-04 | 6 | 113 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 6.54e-04 | 7 | 113 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | extracellularly ATP-gated monoatomic cation channel activity | 6.54e-04 | 7 | 113 | 2 | GO:0004931 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 6.69e-04 | 70 | 113 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 7.77e-04 | 32 | 113 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 7.84e-04 | 73 | 113 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 9.07e-04 | 441 | 113 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 9.29e-04 | 34 | 113 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | ATP-gated ion channel activity | 1.11e-03 | 9 | 113 | 2 | GO:0035381 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.11e-03 | 9 | 113 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | protein kinase inhibitor activity | 1.16e-03 | 81 | 113 | 4 | GO:0004860 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.16e-03 | 207 | 113 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.19e-03 | 208 | 113 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.19e-03 | 37 | 113 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.39e-03 | 10 | 113 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase inhibitor activity | 1.39e-03 | 10 | 113 | 2 | GO:0004862 | |
| GeneOntologyMolecularFunction | kinase inhibitor activity | 1.45e-03 | 86 | 113 | 4 | GO:0019210 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.48e-03 | 296 | 113 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 1.61e-03 | 41 | 113 | 3 | GO:0030291 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 1.69e-03 | 11 | 113 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1E ATP13A1 SLC26A2 SLC26A4 SLC6A9 SLC39A12 SLC10A1 ATP11B P2RX4 P2RX7 TRPM8 TRPV3 | 1.78e-03 | 793 | 113 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase regulator activity | 2.38e-03 | 13 | 113 | 2 | GO:0008603 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCA4 DYNC2H1 ATP13A1 ABCA10 ABCA9 ATP11B ABCA6 ABCA5 DNAH17 | 2.55e-03 | 614 | 113 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 2.76e-03 | 14 | 113 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 3.57e-03 | 259 | 113 | 6 | GO:0019887 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 3.62e-03 | 16 | 113 | 2 | GO:0015116 | |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 3.62e-03 | 16 | 113 | 2 | GO:0034236 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1E ABCC3 ATP13A1 SLC26A2 SLC26A4 SLC6A9 SLC39A12 SLC10A1 P2RX4 TRPM8 TRPV3 | 3.80e-03 | 758 | 113 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | flippase activity | 4.08e-03 | 17 | 113 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 4.34e-03 | 58 | 113 | 3 | GO:0051018 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.58e-03 | 18 | 113 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.95e-03 | 465 | 113 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.00e-03 | 61 | 113 | 3 | GO:1901682 | |
| GeneOntologyBiologicalProcess | lipid transport | ABCC3 ABCA4 RUNX1 CPT1A CPT1B ABCA10 ABCA9 SLC10A1 SLCO1C1 ATP11B P2RX4 P2RX7 ABCA6 ABCA5 | 4.55e-07 | 506 | 109 | 14 | GO:0006869 |
| GeneOntologyBiologicalProcess | lipid localization | ABCC3 ABCA4 RUNX1 CPT1A CPT1B ABCA10 ABCA9 SLC10A1 SLCO1C1 ATP11B P2RX4 P2RX7 ABCA6 ABCA5 | 1.68e-06 | 565 | 109 | 14 | GO:0010876 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.59e-05 | 210 | 109 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.78e-05 | 154 | 109 | 7 | GO:0051928 | |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC3 SLC2A8 SLC26A2 SLC26A4 CPT1A CPT1B SLC6A9 SLC39A12 SLC10A1 SLCO1C1 P2RX4 P2RX7 | 1.80e-05 | 515 | 109 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.89e-05 | 215 | 109 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.89e-05 | 215 | 109 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | phospholipid transfer to membrane | 2.77e-05 | 2 | 109 | 2 | GO:0006649 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC3 SLC26A2 SLC26A4 CPT1A CPT1B SLC6A9 SLC10A1 SLCO1C1 P2RX4 P2RX7 | 6.39e-05 | 410 | 109 | 10 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ABCC3 SLC26A2 SLC26A4 CPT1A CPT1B SLC6A9 SLC10A1 SLCO1C1 P2RX4 P2RX7 | 6.66e-05 | 412 | 109 | 10 | GO:0015849 |
| GeneOntologyBiologicalProcess | cilium movement | 7.46e-05 | 261 | 109 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | regulation of cAMP-dependent protein kinase activity | 7.65e-05 | 16 | 109 | 3 | GO:2000479 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1E ABCC3 DPP10 MCHR1 ATP13A1 SLC26A2 SLC26A4 BAX CEMIP SLC6A9 SLC39A12 SLC10A1 SLCO1C1 ATP11B P2RX4 P2RX7 TRPM8 TRPV3 HTT | 9.92e-05 | 1374 | 109 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.39e-04 | 213 | 109 | 7 | GO:0015718 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.56e-04 | 217 | 109 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | carnitine shuttle | 1.65e-04 | 4 | 109 | 2 | GO:0006853 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport into cytosol | 1.78e-04 | 21 | 109 | 3 | GO:0010524 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1E ABCC3 DPP10 ATP13A1 SLC26A2 SLC26A4 BAX CEMIP SLC6A9 SLC39A12 ATP11B P2RX4 P2RX7 TRPM8 TRPV3 HTT | 2.48e-04 | 1115 | 109 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | negative regulation of cAMP/PKA signal transduction | 2.74e-04 | 5 | 109 | 2 | GO:0141162 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 2.84e-04 | 109 | 109 | 5 | GO:1904427 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.22e-04 | 112 | 109 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport into cytosol | 3.83e-04 | 27 | 109 | 3 | GO:0010522 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 4.00e-04 | 334 | 109 | 8 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 4.00e-04 | 334 | 109 | 8 | GO:0001894 | |
| Domain | ABC_A | 4.31e-09 | 12 | 107 | 5 | IPR026082 | |
| Domain | ABC_tran | 3.10e-07 | 48 | 107 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.10e-07 | 48 | 107 | 6 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.51e-07 | 49 | 107 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 3.97e-07 | 50 | 107 | 6 | IPR003439 | |
| Domain | AAA | 1.92e-05 | 144 | 107 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.92e-05 | 144 | 107 | 7 | IPR003593 | |
| Domain | ABC_transporter_CS | 9.64e-05 | 42 | 107 | 4 | IPR017871 | |
| Domain | CPT_N | 9.72e-05 | 3 | 107 | 2 | IPR032476 | |
| Domain | CPT_N | 9.72e-05 | 3 | 107 | 2 | PF16484 | |
| Domain | cAMP_dep_PK_reg_su | 1.94e-04 | 4 | 107 | 2 | IPR012198 | |
| Domain | RIIa | 4.80e-04 | 6 | 107 | 2 | SM00394 | |
| Domain | P2X_receptor | 6.70e-04 | 7 | 107 | 2 | PF00864 | |
| Domain | P2X_purnocptor | 6.70e-04 | 7 | 107 | 2 | IPR001429 | |
| Domain | Carn_acyl_trans | 6.70e-04 | 7 | 107 | 2 | IPR000542 | |
| Domain | S04_transporter_CS | 6.70e-04 | 7 | 107 | 2 | IPR018045 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 2.60.490.10 | |
| Domain | RIIa | 6.70e-04 | 7 | 107 | 2 | PF02197 | |
| Domain | Carn_acyltransf | 6.70e-04 | 7 | 107 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 6.70e-04 | 7 | 107 | 2 | PS00439 | |
| Domain | ACYLTRANSF_C_2 | 6.70e-04 | 7 | 107 | 2 | PS00440 | |
| Domain | P2X_RECEPTOR | 6.70e-04 | 7 | 107 | 2 | PS01212 | |
| Domain | P2X_extracellular_dom | 6.70e-04 | 7 | 107 | 2 | IPR027309 | |
| Domain | SLC26A | 1.42e-03 | 10 | 107 | 2 | PS01130 | |
| Domain | STAS | 1.73e-03 | 11 | 107 | 2 | PS50801 | |
| Domain | STAS | 1.73e-03 | 11 | 107 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 1.73e-03 | 11 | 107 | 2 | IPR001902 | |
| Domain | STAS_dom | 1.73e-03 | 11 | 107 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 1.73e-03 | 11 | 107 | 2 | IPR011547 | |
| Domain | - | 1.73e-03 | 11 | 107 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 1.73e-03 | 11 | 107 | 2 | PF00916 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 3.25e-03 | 15 | 107 | 2 | IPR003117 | |
| Domain | cNMP-bd_CS | 3.70e-03 | 16 | 107 | 2 | IPR018488 | |
| Domain | ARM-like | 4.62e-03 | 270 | 107 | 6 | IPR011989 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC3 SLC29A3 ABCA4 SLC2A8 ATP13A1 SLC26A2 SLC26A4 RUNX1 ABCA10 ADCY3 ABCA9 SLC6A9 SLCO1C1 ATP11B ABCA6 ABCA5 PRKAR1A PRKAR1B TRPM8 TRPV3 | 1.52e-08 | 736 | 87 | 20 | M27287 |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.71e-07 | 44 | 87 | 6 | M11911 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC3 SLC29A3 ABCA4 SLC2A8 ATP13A1 SLC26A2 SLC26A4 ABCA9 SLC6A9 SLCO1C1 ATP11B ABCA6 ABCA5 PRKAR1A PRKAR1B TRPM8 TRPV3 | 7.23e-07 | 681 | 87 | 17 | MM14985 |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 3.88e-06 | 18 | 87 | 4 | M524 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.11e-05 | 103 | 87 | 6 | M758 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.20e-04 | 16 | 87 | 3 | MM14492 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.34e-04 | 314 | 87 | 9 | M39428 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.45e-04 | 17 | 87 | 3 | M26995 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.45e-04 | 17 | 87 | 3 | MM14552 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.40e-04 | 20 | 87 | 3 | M759 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.62e-04 | 99 | 87 | 5 | MM14986 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M48989 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 4.18e-04 | 24 | 87 | 3 | MM1467 | |
| Pathway | WP_EFFECTS_OF_MFN2_MUTATION | 4.18e-04 | 24 | 87 | 3 | M48308 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 4.73e-04 | 25 | 87 | 3 | M85 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 5.33e-04 | 26 | 87 | 3 | MM14495 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 5.40e-04 | 108 | 87 | 5 | M17034 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 5.56e-04 | 6 | 87 | 2 | MM14628 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY | 5.56e-04 | 6 | 87 | 2 | M47708 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 7.39e-04 | 29 | 87 | 3 | M39762 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47577 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 7.75e-04 | 7 | 87 | 2 | M47896 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47435 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050 | 7.75e-04 | 7 | 87 | 2 | M47709 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 8.67e-04 | 249 | 87 | 7 | M5988 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS | 1.03e-03 | 8 | 87 | 2 | M47571 | |
| Pathway | WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE | 1.03e-03 | 8 | 87 | 2 | MM15965 | |
| Pathway | WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION | 1.03e-03 | 8 | 87 | 2 | M48325 | |
| Pathway | WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE | 1.03e-03 | 8 | 87 | 2 | M39906 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY | 1.03e-03 | 8 | 87 | 2 | M47740 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 1.08e-03 | 33 | 87 | 3 | M277 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.08e-03 | 33 | 87 | 3 | M11575 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.32e-03 | 9 | 87 | 2 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.32e-03 | 9 | 87 | 2 | MM15084 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.52e-03 | 37 | 87 | 3 | M749 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1352 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1530 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1377 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.77e-03 | 39 | 87 | 3 | MM14496 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.00e-03 | 11 | 87 | 2 | MM1521 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M5576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS | 2.00e-03 | 11 | 87 | 2 | M47626 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 2.00e-03 | 11 | 87 | 2 | MM1455 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M12399 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M19829 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS | 2.00e-03 | 11 | 87 | 2 | M47693 | |
| Pathway | KEGG_APOPTOSIS | 2.04e-03 | 87 | 87 | 4 | M8492 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.04e-03 | 41 | 87 | 3 | M512 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 2.34e-03 | 43 | 87 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 2.34e-03 | 43 | 87 | 3 | M933 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.39e-03 | 12 | 87 | 2 | M7968 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 2.39e-03 | 12 | 87 | 2 | M27363 | |
| Pathway | REACTOME_ALK_MUTANTS_BIND_TKIS | 2.39e-03 | 12 | 87 | 2 | M42522 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 2.39e-03 | 12 | 87 | 2 | M48096 | |
| Pathway | BIOCARTA_DREAM_PATHWAY | 2.39e-03 | 12 | 87 | 2 | MM1475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 2.39e-03 | 12 | 87 | 2 | M47953 | |
| Pubmed | 7.76e-11 | 22 | 114 | 6 | 8894702 | ||
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 2.26e-08 | 10 | 114 | 4 | 11435397 | |
| Pubmed | Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. | 3.41e-07 | 5 | 114 | 3 | 12532264 | |
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 19273598 | ||
| Pubmed | SH3TC2 DYNC2H1 ATP13A1 DGKD CLSTN1 BIRC6 PRX DNAH17 ZNF616 REXO1L1P NUP160 | 7.20e-07 | 493 | 114 | 11 | 15368895 | |
| Pubmed | 1.11e-06 | 24 | 114 | 4 | 17553423 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 15640352 | ||
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 22915101 | ||
| Pubmed | 9.58e-06 | 13 | 114 | 3 | 19895210 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17089095 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10381357 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24145669 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 35254644 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 1448119 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23907941 | ||
| Pubmed | No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus. | 1.07e-05 | 2 | 114 | 2 | 18211414 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 22451435 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23303206 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23220614 | ||
| Pubmed | Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. | 1.07e-05 | 2 | 114 | 2 | 19403602 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 35119925 | ||
| Pubmed | Involvement of P2X4 receptor in P2X7 receptor-dependent cell death of mouse macrophages. | 1.07e-05 | 2 | 114 | 2 | 22349510 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23773998 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25521332 | ||
| Pubmed | P2X currents in peritoneal macrophages of wild type and P2X4 -/- mice. | 1.07e-05 | 2 | 114 | 2 | 17825926 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9070950 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25938443 | ||
| Pubmed | Olfactory neurons in bax knockout mice are protected from bulbectomy-induced apoptosis. | 1.07e-05 | 2 | 114 | 2 | 14561915 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 22309278 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 31401785 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 22988022 | ||
| Pubmed | Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis. | 1.07e-05 | 2 | 114 | 2 | 28326637 | |
| Pubmed | Atypical P2X receptor pharmacology in two human osteoblast-like cell lines. | 1.07e-05 | 2 | 114 | 2 | 19226284 | |
| Pubmed | Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. | 1.07e-05 | 2 | 114 | 2 | 11350920 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 38740782 | ||
| Pubmed | Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. | 1.07e-05 | 2 | 114 | 2 | 17675190 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 21434306 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19304656 | ||
| Pubmed | Expression and regulation of carnitine palmitoyltransferase-Ialpha and -Ibeta genes. | 1.07e-05 | 2 | 114 | 2 | 10408760 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23428419 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8696339 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17785580 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 28697680 | ||
| Pubmed | Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. | 1.07e-05 | 2 | 114 | 2 | 15578095 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 14507967 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 38953020 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17124493 | ||
| Pubmed | Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation. | 1.07e-05 | 2 | 114 | 2 | 38426095 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8407966 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 32358018 | ||
| Pubmed | Deleterious variants in X-linked CFAP47 induce asthenoteratozoospermia and primary male infertility. | 1.07e-05 | 2 | 114 | 2 | 33472045 | |
| Pubmed | Molecular diagnosis of putative Stargardt disease by capture next generation sequencing. | 1.07e-05 | 2 | 114 | 2 | 24763286 | |
| Pubmed | Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. | 1.07e-05 | 2 | 114 | 2 | 10479688 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9013572 | ||
| Pubmed | Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages. | 1.07e-05 | 2 | 114 | 2 | 22405772 | |
| Pubmed | Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo. | 1.22e-05 | 14 | 114 | 3 | 31749402 | |
| Pubmed | 1.24e-05 | 325 | 114 | 8 | 36168628 | ||
| Pubmed | RBM19 is essential for preimplantation development in the mouse. | 1.52e-05 | 15 | 114 | 3 | 19087264 | |
| Pubmed | Dynamic regulation of the expression of neurotrophin receptors by Runx3. | 1.52e-05 | 15 | 114 | 3 | 18385258 | |
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 1.52e-05 | 15 | 114 | 3 | 2165385 | |
| Pubmed | Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancer. | 1.86e-05 | 16 | 114 | 3 | 21146511 | |
| Pubmed | Bax cleavage implicates caspase-dependent H2O2-induced apoptosis of hepatocytes. | 3.19e-05 | 3 | 114 | 2 | 12579342 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 10825294 | ||
| Pubmed | Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. | 3.19e-05 | 3 | 114 | 2 | 17197037 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 20683843 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28500630 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 35203267 | ||
| Pubmed | Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission. | 3.19e-05 | 3 | 114 | 2 | 21609830 | |
| Pubmed | miR-98 and its host gene Huwe1 target Caspase-3 in Silica nanoparticles-treated male germ cells. | 3.19e-05 | 3 | 114 | 2 | 26263183 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 35653384 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19692349 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19223905 | ||
| Pubmed | Genomic structure of and a cardiac promoter for the mouse carnitine palmitoyltransferase II gene. | 3.19e-05 | 3 | 114 | 2 | 8307575 | |
| Pubmed | [Apoptosis-inducing effect of clostridium difficile toxin A on K562 cells and its mechanism]. | 3.19e-05 | 3 | 114 | 2 | 21729540 | |
| Pubmed | Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia. | 3.19e-05 | 3 | 114 | 2 | 18415689 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 29175331 | ||
| Pubmed | Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. | 3.19e-05 | 3 | 114 | 2 | 29875325 | |
| Pubmed | Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. | 3.19e-05 | 3 | 114 | 2 | 19552691 | |
| Pubmed | Bax limits adult neural stem cell persistence through caspase and IP3 receptor activation. | 3.19e-05 | 3 | 114 | 2 | 15947791 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23170075 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18407780 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 15657356 | ||
| Pubmed | HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. | 3.19e-05 | 3 | 114 | 2 | 10942389 | |
| Pubmed | Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. | 3.19e-05 | 3 | 114 | 2 | 17299767 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 29412153 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 29750299 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 22949938 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 33838119 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 12488331 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24161344 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 3479018 | ||
| Pubmed | Immunohistochemical localization of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts. | 3.19e-05 | 3 | 114 | 2 | 18814044 | |
| Pubmed | Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. | 3.19e-05 | 3 | 114 | 2 | 18852390 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17823127 | ||
| Pubmed | Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. | 3.19e-05 | 3 | 114 | 2 | 11787859 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 37166584 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28941661 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 9894607 | ||
| Pubmed | Selenium compounds induced ROS-dependent apoptosis in myelodysplasia cells. | 3.19e-05 | 3 | 114 | 2 | 23900644 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 30692915 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 4.88e-06 | 98 | 114 | 5 | chr17q24 | |
| GeneFamily | ATP binding cassette subfamily A | 1.82e-09 | 14 | 73 | 5 | 805 | |
| GeneFamily | Solute carriers | SLC29A3 SLC2A8 SLC26A2 SLC26A4 SLC6A9 SLC39A12 SLC10A1 SLCO1C1 | 1.88e-04 | 395 | 73 | 8 | 752 |
| GeneFamily | Purinergic receptors P2X | 3.33e-04 | 7 | 73 | 2 | 214 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-08 | 200 | 114 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-08 | 200 | 114 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-08 | 200 | 114 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-07 | 159 | 114 | 7 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-07 | 159 | 114 | 7 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.35e-07 | 181 | 114 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.86e-07 | 184 | 114 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.24e-07 | 191 | 114 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.69e-07 | 193 | 114 | 7 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.69e-07 | 193 | 114 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.17e-07 | 195 | 114 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-07 | 195 | 114 | 7 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 7.95e-07 | 198 | 114 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.50e-07 | 200 | 114 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.50e-07 | 200 | 114 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.50e-07 | 200 | 114 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 153 | 114 | 6 | c4dcdcaa672929c1da870e9fb8ada1bb030ad12f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 163 | 114 | 6 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 163 | 114 | 6 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-06 | 175 | 114 | 6 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.22e-06 | 185 | 114 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 8.22e-06 | 185 | 114 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.48e-06 | 186 | 114 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.74e-06 | 187 | 114 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 8.74e-06 | 187 | 114 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-06 | 189 | 114 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-06 | 189 | 114 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-06 | 189 | 114 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-06 | 189 | 114 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.57e-06 | 190 | 114 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 9.57e-06 | 190 | 114 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-06 | 190 | 114 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.86e-06 | 191 | 114 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.86e-06 | 191 | 114 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.02e-05 | 192 | 114 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 192 | 114 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 193 | 114 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 194 | 114 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-05 | 194 | 114 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-05 | 194 | 114 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-05 | 194 | 114 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 194 | 114 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 194 | 114 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.11e-05 | 195 | 114 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-05 | 196 | 114 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-05 | 196 | 114 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.14e-05 | 196 | 114 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 197 | 114 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 197 | 114 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 197 | 114 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.18e-05 | 197 | 114 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 198 | 114 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 198 | 114 | 6 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 198 | 114 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-05 | 198 | 114 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.25e-05 | 199 | 114 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-05 | 199 | 114 | 6 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 199 | 114 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-05 | 199 | 114 | 6 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 199 | 114 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 200 | 114 | 6 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 200 | 114 | 6 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 200 | 114 | 6 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 69 | 114 | 4 | 3074ec10315fb21048215125ec08b0d7922da3d9 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 69 | 114 | 4 | f731d4500b139a8bef5c9185368509bf5a3791db | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 69 | 114 | 4 | 40eb84fe36da5a4a82bd9b2d962b829e2c97a059 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 141 | 114 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 141 | 114 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.36e-05 | 151 | 114 | 5 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.36e-05 | 151 | 114 | 5 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 162 | 114 | 5 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 162 | 114 | 5 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 6.45e-05 | 164 | 114 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 167 | 114 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-05 | 168 | 114 | 5 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 168 | 114 | 5 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-05 | 168 | 114 | 5 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-05 | 168 | 114 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 168 | 114 | 5 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-05 | 171 | 114 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 173 | 114 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.76e-05 | 175 | 114 | 5 | 53e6f1f8dd482dfa2539e068dacefbb6e08443bc | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-05 | 176 | 114 | 5 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.00e-05 | 176 | 114 | 5 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 177 | 114 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 177 | 114 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 178 | 114 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| Drug | docetaxel | 3.13e-07 | 133 | 112 | 8 | ctd:C067311 | |
| Drug | glibenclamide | ABCC3 ABCA4 DLK1 CPT1A CPT1B ABCA10 ADCY3 ABCA9 ABCA6 ABCA5 EHMT1 PRKAR1A | 4.10e-07 | 382 | 112 | 12 | CID000003488 |
| Drug | Cephalothin | 7.26e-07 | 15 | 112 | 4 | ctd:D002512 | |
| Drug | NSC606985 | 1.15e-06 | 5 | 112 | 3 | CID000354677 | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 4.60e-06 | 190 | 112 | 8 | 7070_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A | 5.37e-06 | 194 | 112 | 8 | 1274_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 4658_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | 6.23e-06 | 198 | 112 | 8 | 7270_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 6.23e-06 | 198 | 112 | 8 | 5837_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; PC3; HT_HG-U133A | 6.23e-06 | 198 | 112 | 8 | 6702_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 6.47e-06 | 199 | 112 | 8 | 1500_UP | |
| Drug | Menthol | 1.04e-05 | 28 | 112 | 4 | ctd:D008610 | |
| Drug | smilageninoside | 1.36e-05 | 10 | 112 | 3 | CID000197391 | |
| Drug | nonyl acridine orange | 1.36e-05 | 10 | 112 | 3 | CID000115086 | |
| Drug | 3,4,3',4'-tetrachlorobiphenyl | MASP1 CASP3 BAX HUWE1 CPT1A CLIP1 SLC6A9 PDE4DIP SARDH HSD17B11 IL6R | 1.48e-05 | 453 | 112 | 11 | ctd:C028451 |
| Drug | Methamphetamine | MAGEA4 SLC29A3 OVCH2 KAT6A CASP3 BAX CUL9 RENBP NUF2 CLIP1 ADCY3 SLC6A9 PROM1 SLC39A12 SLC10A1 P2RX4 TLE2 ZMIZ2 PDE4DIP RNF225 | 1.50e-05 | 1401 | 112 | 20 | ctd:D008694 |
| Drug | sodium | ABCC3 SLC29A3 MCHR1 SLC2A8 SLC26A2 SLC26A4 HUWE1 CPT1B ADCY3 SLC6A9 LIG4 SLC10A1 ATP11B P2RX4 P2RX7 PRKAR1A | 1.53e-05 | 944 | 112 | 16 | CID000000923 |
| Drug | physcione | 1.86e-05 | 11 | 112 | 3 | ctd:C008905 | |
| Drug | marchantin C | 2.40e-05 | 2 | 112 | 2 | CID005319272 | |
| Drug | ethyl eicosapentaenoic acid | 2.40e-05 | 2 | 112 | 2 | ctd:C495711 | |
| Drug | Hypoxanthine | 2.47e-05 | 12 | 112 | 3 | ctd:D019271 | |
| Drug | etomoxiryl-CoA | 2.47e-05 | 12 | 112 | 3 | CID003081714 | |
| Drug | DPCPX | 2.49e-05 | 117 | 112 | 6 | CID000001329 | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.99e-05 | 179 | 112 | 7 | 3895_UP | |
| Drug | Tea | 3.60e-05 | 38 | 112 | 4 | ctd:D013662 | |
| Drug | beta-hexachlorocyclohexane | 3.78e-05 | 126 | 112 | 6 | ctd:C023888 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 3.82e-05 | 186 | 112 | 7 | 6831_UP | |
| Drug | 3-isoreserpine | 4.37e-05 | 190 | 112 | 7 | CID000005052 | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.98e-05 | 194 | 112 | 7 | 6710_UP | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 4614_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 7312_DN | |
| Drug | Nicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 2058_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; HL60; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 2196_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 4597_UP | |
| Drug | Ronidazole [7681-76-7]; Up 200; 20uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 7131_UP | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 5833_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 5232_UP | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 6602_DN | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; HL60; HG-U133A | 5.32e-05 | 196 | 112 | 7 | 1720_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 2141_DN | |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 4955_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 3717_UP | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 6255_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 6688_UP | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 2797_UP | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 4594_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 6965_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 5.85e-05 | 199 | 112 | 7 | 985_UP | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; HL60; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 2461_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 5475_UP | |
| Drug | Buserelin | 6.19e-05 | 16 | 112 | 3 | ctd:D002064 | |
| Drug | spiroquinazoline | 7.17e-05 | 3 | 112 | 2 | ctd:C088106 | |
| Drug | CDRI-97-78 | 7.17e-05 | 3 | 112 | 2 | ctd:C574493 | |
| Drug | xanthoangelol | 7.17e-05 | 3 | 112 | 2 | ctd:C068244 | |
| Drug | xanthoangelol H | 7.17e-05 | 3 | 112 | 2 | CID006479089 | |
| Drug | mirabijalone E | 7.17e-05 | 3 | 112 | 2 | ctd:C000596409 | |
| Drug | ginkgolide K | 7.17e-05 | 3 | 112 | 2 | ctd:C481151 | |
| Drug | Epirubicin | 8.41e-05 | 47 | 112 | 4 | ctd:D015251 | |
| Drug | NSC640330 | 9.14e-05 | 48 | 112 | 4 | CID000005204 | |
| Drug | Methoxsalen | 9.14e-05 | 48 | 112 | 4 | ctd:D008730 | |
| Drug | Beauvericin | 1.06e-04 | 19 | 112 | 3 | CID000105014 | |
| Drug | substance B | 1.24e-04 | 20 | 112 | 3 | CID000433154 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 1.26e-04 | 302 | 112 | 8 | ctd:D003633 | |
| Drug | AC1L1FF5 | 1.28e-04 | 157 | 112 | 6 | CID000003209 | |
| Drug | dioscin | 1.35e-04 | 53 | 112 | 4 | ctd:C019357 | |
| Drug | Lanthanoid Series Elements | 1.43e-04 | 4 | 112 | 2 | ctd:D028581 | |
| Drug | ioversol | 1.43e-04 | 4 | 112 | 2 | ctd:C054871 | |
| Drug | dehydroabietylamine acetate | 1.43e-04 | 4 | 112 | 2 | CID000062034 | |
| Drug | 2,6-difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide | 1.43e-04 | 4 | 112 | 2 | ctd:C583716 | |
| Drug | macitentan | 1.43e-04 | 4 | 112 | 2 | ctd:C533860 | |
| Drug | AC1LAY6G | 1.43e-04 | 4 | 112 | 2 | CID000497896 | |
| Drug | Menthol | 1.43e-04 | 4 | 112 | 2 | DB00825 | |
| Drug | bornyl caffeate | 1.43e-04 | 4 | 112 | 2 | ctd:C115950 | |
| Drug | NCI60_039755 | 1.43e-04 | 4 | 112 | 2 | CID000401428 | |
| Drug | astin B | 1.43e-04 | 4 | 112 | 2 | ctd:C082414 | |
| Drug | cheliensisin A | 1.43e-04 | 4 | 112 | 2 | CID005315815 | |
| Drug | glaucocalyxin A | 1.43e-04 | 4 | 112 | 2 | ctd:C055124 | |
| Drug | foliol | 1.43e-04 | 4 | 112 | 2 | CID000637194 | |
| Drug | rhodostomin | 1.43e-04 | 4 | 112 | 2 | ctd:C072026 | |
| Drug | EUK-172 | 1.43e-04 | 4 | 112 | 2 | ctd:C580814 | |
| Drug | anthracenylmethyl homospermidine | 1.43e-04 | 4 | 112 | 2 | ctd:C529696 | |
| Drug | ferrous oxide | 1.43e-04 | 4 | 112 | 2 | ctd:C034236 | |
| Drug | gastrodin | 1.44e-04 | 21 | 112 | 3 | ctd:C045345 | |
| Drug | Cholesterol, Dietary | 1.50e-04 | 102 | 112 | 5 | ctd:D002791 | |
| Drug | AICA ribonucleotide | 1.50e-04 | 102 | 112 | 5 | ctd:C031143 | |
| Drug | verapamil | CACNA1E ABCC3 ABCA4 SLC26A4 BIRC6 ABCA10 ADCY3 ABCA9 ABCA6 ABCA5 | 1.55e-04 | 490 | 112 | 10 | CID000002520 |
| Drug | AICAR monophosphate | 1.57e-04 | 163 | 112 | 6 | CID000000200 | |
| Drug | Metformin | 1.63e-04 | 400 | 112 | 9 | ctd:D008687 | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.74e-04 | 166 | 112 | 6 | 2446_UP | |
| Drug | fipronil | ABCC3 MASP1 SLC29A3 CASP3 DLK1 CLIP1 SLC6A9 FASN SLC10A1 DEPDC5 HSD17B11 | 1.76e-04 | 597 | 112 | 11 | ctd:C082360 |
| Drug | nickel acetate | 1.88e-04 | 107 | 112 | 5 | ctd:C119536 | |
| Drug | Glycochenodeoxycholic Acid | 1.91e-04 | 23 | 112 | 3 | ctd:D005999 | |
| Drug | butylbenzyl phthalate | 1.96e-04 | 108 | 112 | 5 | ctd:C027561 | |
| Drug | Doxycycline | 2.19e-04 | 60 | 112 | 4 | ctd:D004318 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.31e-04 | 175 | 112 | 6 | 2485_UP | |
| Drug | TDGA-carnitine | 2.38e-04 | 5 | 112 | 2 | CID000196388 | |
| Drug | 4 t ha | 2.38e-04 | 5 | 112 | 2 | CID000124503 | |
| Drug | ar-turmerone | 2.38e-04 | 5 | 112 | 2 | ctd:C078098 | |
| Drug | 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline | 2.38e-04 | 5 | 112 | 2 | ctd:C067372 | |
| Drug | bromotetrandrine | 2.38e-04 | 5 | 112 | 2 | ctd:C514835 | |
| Disease | Colorectal Neoplasms | 1.04e-05 | 277 | 111 | 8 | C0009404 | |
| Disease | intestinal disease (biomarker_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:5295 (biomarker_via_orthology) | |
| Disease | Stargardt disease | 4.20e-05 | 3 | 111 | 2 | cv:C0271093 | |
| Disease | brain glioma (implicated_via_orthology) | 1.39e-04 | 5 | 111 | 2 | DOID:0060108 (implicated_via_orthology) | |
| Disease | STARGARDT DISEASE 1 (disorder) | 1.39e-04 | 5 | 111 | 2 | C1855465 | |
| Disease | Malignant neoplasm of breast | MAGEA4 ABCA4 DYNC2H1 C1orf87 LAMA2 ARFGEF2 BAX CPT1A CLIP1 SLC39A12 FASN EHMT1 UTP20 | 2.03e-04 | 1074 | 111 | 13 | C0006142 |
| Disease | Stargardt's disease | 2.08e-04 | 6 | 111 | 2 | C0271093 | |
| Disease | alcohol drinking | 2.52e-04 | 81 | 111 | 4 | EFO_0004329 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.64e-04 | 150 | 111 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | stromal cell-derived factor 1 measurement | 2.91e-04 | 7 | 111 | 2 | EFO_0020756 | |
| Disease | Mental Depression | 4.09e-04 | 254 | 111 | 6 | C0011570 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.56e-04 | 169 | 111 | 5 | DOID:3908 (is_marker_for) | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 4.63e-04 | 40 | 111 | 3 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | pre-malignant neoplasm (implicated_via_orthology) | 4.96e-04 | 9 | 111 | 2 | DOID:0060071 (implicated_via_orthology) | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 6.55e-04 | 45 | 111 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 7.27e-04 | 107 | 111 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Streptozotocin Diabetes | 7.52e-04 | 108 | 111 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 7.52e-04 | 108 | 111 | 4 | C0011853 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 7.52e-04 | 108 | 111 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | Alloxan Diabetes | 7.52e-04 | 108 | 111 | 4 | C0002152 | |
| Disease | Depressive disorder | 8.03e-04 | 289 | 111 | 6 | C0011581 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 9.03e-04 | 12 | 111 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 9.75e-04 | 200 | 111 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | Polydactyly | 1.01e-03 | 117 | 111 | 4 | C0152427 | |
| Disease | Abnormality of refraction | 1.01e-03 | 673 | 111 | 9 | HP_0000539 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.06e-03 | 13 | 111 | 2 | cv:C4082197 | |
| Disease | microsatellite instability measurement, colorectal cancer, overall survival | 1.06e-03 | 13 | 111 | 2 | EFO_0000638, EFO_0007054, MONDO_0005575 | |
| Disease | Colorectal Carcinoma | 1.36e-03 | 702 | 111 | 9 | C0009402 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.37e-03 | 127 | 111 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Diabetic Angiopathies | 1.63e-03 | 16 | 111 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 1.63e-03 | 16 | 111 | 2 | C0025945 | |
| Disease | phosphatidylcholine 38:6 measurement | 1.63e-03 | 16 | 111 | 2 | EFO_0010388 | |
| Disease | heart disease (biomarker_via_orthology) | 1.84e-03 | 17 | 111 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | glycochenodeoxycholate measurement | 1.84e-03 | 17 | 111 | 2 | EFO_0010490 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 2.06e-03 | 18 | 111 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | Age-related macular degeneration | 2.06e-03 | 18 | 111 | 2 | cv:C0242383 | |
| Disease | stomach cancer (is_marker_for) | 2.07e-03 | 142 | 111 | 4 | DOID:10534 (is_marker_for) | |
| Disease | cognitive function measurement, self reported educational attainment | 2.28e-03 | 355 | 111 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | migraine disorder | 2.35e-03 | 357 | 111 | 6 | MONDO_0005277 | |
| Disease | corneal hysteresis | 2.55e-03 | 20 | 111 | 2 | EFO_0010066 | |
| Disease | kidney disease (biomarker_via_orthology) | 2.81e-03 | 21 | 111 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 2.87e-03 | 75 | 111 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | serum metabolite measurement | CACNA1E SH3TC2 RUNX1 CPT1A FMO6P SLC39A12 RRN3 DNAH17 TRPM8 SARDH | 3.03e-03 | 945 | 111 | 10 | EFO_0005653 |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 3.08e-03 | 22 | 111 | 2 | DOID:12930 (biomarker_via_orthology) | |
| Disease | impotence (biomarker_via_orthology) | 3.08e-03 | 22 | 111 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Disproportionate short stature | 3.10e-03 | 77 | 111 | 3 | C0878659 | |
| Disease | platelet crit | SCFD2 CASS4 ATP13A1 BAX DGKD DLK1 NIBAN2 RUNX1 FBXO47 NUP160 | 3.19e-03 | 952 | 111 | 10 | EFO_0007985 |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.37e-03 | 23 | 111 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.37e-03 | 23 | 111 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.37e-03 | 23 | 111 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.37e-03 | 23 | 111 | 2 | C0014556 | |
| Disease | Huntington's disease (is_implicated_in) | 3.37e-03 | 23 | 111 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 3.67e-03 | 24 | 111 | 2 | DOID:0081292 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRTKKSSVQEILFPL | 26 | Q8WWZ7 | |
| ELFKHLCISGTPKIR | 2061 | Q9NR09 | |
| RIICEKTLSFPKQAI | 141 | Q9NQ75 | |
| RLPKLKAVFDCVVTS | 1271 | Q15878 | |
| PVKTLSEGIKRKLCF | 1336 | Q8WWZ4 | |
| RKLCFVLSILGNPSV | 1346 | Q8WWZ4 | |
| KRKLSTAIALIGCPP | 2076 | P78363 | |
| KGRIVTFLTCKTFDP | 576 | Q9UKQ2 | |
| APVKTLSEGIKRKLC | 1416 | Q8IUA7 | |
| KRKLCFVLSILGNPS | 1426 | Q8IUA7 | |
| GCFLFISRSKPLKTL | 1026 | Q9HD20 | |
| QKLTAGITRKLCFVL | 1411 | Q8N139 | |
| LVFRSLCKLSMKPLG | 376 | Q9Y6D5 | |
| KGIIKKCRTSPDAFV | 556 | P50416 | |
| ACFITQLLPVKRKLG | 381 | P06280 | |
| PGIRRLKITSTIKCF | 616 | O94985 | |
| KPEFTGLTCVKKRAL | 236 | P80370 | |
| VCSLESFVKLFIPKR | 16 | Q8NBQ5 | |
| DFVGIICTRLSPKKI | 216 | O14874 | |
| DRCRSLTGKPKLFII | 146 | P42574 | |
| FLCGKPVRPKLTVTI | 401 | Q8WUJ3 | |
| KLFKCGSVVAPITDL | 666 | Q8N608 | |
| LPTVKILCQRFSKRG | 231 | Q8N0U7 | |
| TPAVSCIIRKIKAIG | 96 | P36871 | |
| KGFRLLLASPSACLK | 486 | Q9ULC6 | |
| AKTDPFCPIFRLGKI | 221 | Q99571 | |
| VCAIVPFRSKILLAK | 146 | O15438 | |
| SKIRAFILPKAEVCV | 321 | Q96TA1 | |
| PNLATLCAKKGLLFV | 31 | Q96NI6 | |
| CRIIFSKAKPSVLAL | 191 | P51959 | |
| FLLLPACVTATKRIT | 946 | O75140 | |
| RVAPPGKKCAFVLTR | 106 | P51606 | |
| LPIKKSTALKVALFC | 231 | Q9NPJ1 | |
| RLGTCKVDISALPLK | 431 | Q6DN12 | |
| RCFPVIFGKASESLK | 146 | P43358 | |
| KTLLKVVGFCRGPAV | 451 | Q6ZU64 | |
| CLAVLKGLYLLRSKP | 51 | Q9BVA6 | |
| CPKAKRTSRFLSGII | 111 | Q9BZD4 | |
| LSETLPGSVKKRVCF | 61 | Q9UHL3 | |
| KMGITTFPKCILRLS | 36 | Q8N456 | |
| SIPFRGCIRSLKLTK | 3081 | P24043 | |
| RILCGTLSIKPSVKE | 291 | O60774 | |
| LLCKITFKSRPSLAP | 241 | Q86UU5 | |
| TFPLSGHCKVVVKLL | 326 | Q9Y5H7 | |
| LFGLLVKLCVGSPVR | 1066 | Q7Z6Z7 | |
| APLSTCRKLGLLLKY | 436 | Q6NXR0 | |
| QLRLSCKATGIPLPK | 4276 | Q96RW7 | |
| VLIPCTIGIVLKSKR | 166 | Q14973 | |
| CLKFSPELTVRVKAL | 241 | Q92794 | |
| KKPGACITTSELFRK | 501 | Q99572 | |
| ALFACKTLGLKEVSP | 3691 | Q8NCM8 | |
| CSPVLSRKQKGKVLL | 431 | P42858 | |
| FGTLLCIAIVLRFKK | 376 | P08887 | |
| FVLKPRCLQKGSLTI | 131 | P49917 | |
| GKRIVLITPSGCIFL | 126 | Q9H799 | |
| TCLDKLRFGFKKITP | 2301 | Q9UFH2 | |
| CFPLRAKVVVTKGRV | 146 | Q92847 | |
| KSVCVLSKLPLYGLL | 116 | Q8NBF6 | |
| FASKLVLKALCTKVP | 116 | Q07812 | |
| SLSLKKPIILRSSGC | 276 | Q8IX06 | |
| RLPVSKKTLLCSFQV | 96 | Q9UBX1 | |
| ICSLAAIFPRAFPKK | 676 | O60266 | |
| SKCAQPVFLLLVIKS | 101 | Q9Y2A9 | |
| TCLPVCGLPKFSRKL | 431 | P48740 | |
| TKFRKPSVATLVICL | 221 | Q99705 | |
| KRILCGIKELSRSAP | 1196 | Q16760 | |
| SLGLLFKRCTLLLPT | 116 | Q5MNV8 | |
| AATVVARGPLKCVKL | 336 | P10644 | |
| AATVVARGPLKCVKL | 336 | P31321 | |
| IPGKLLFSLVKRYLC | 251 | Q8IWT3 | |
| LSTLVKGTRRPVTCK | 141 | Q9NX74 | |
| LLQAVLKRGLKPSCT | 766 | P49327 | |
| AELGKVFPLKRLKCS | 251 | Q9BRP7 | |
| KKFIAVPARLQTRCG | 581 | D6RIA3 | |
| SRSLIKTLLEKTGCP | 61 | Q504Y0 | |
| TFKPIFECVITGKLI | 2376 | Q6ZTR5 | |
| CLPFVLAAAVSRKKK | 276 | Q9H9B1 | |
| CEPLKGIFTRPSKLT | 111 | P30622 | |
| KGLIKKCRTSPDAFV | 556 | Q92523 | |
| TCKKGPVIELVFSVL | 226 | Q8NGC1 | |
| LIFRLSLCSKILPGF | 176 | Q8NH06 | |
| SPKLIVGLFCDKKTI | 76 | Q8NH83 | |
| LKSKSTRKPLACIIG | 521 | Q9BTC8 | |
| SGTLPRKCKKELLAV | 391 | Q96KR7 | |
| CNKTLPIAFKVVALG | 81 | Q01196 | |
| LARAKFIPLITVKSC | 411 | Q9NYV6 | |
| SKALPGFVLLRTCLI | 376 | Q9BZD2 | |
| PLKRTCIFKFLGAVA | 2641 | O75691 | |
| LRIPSTKRVCLVGKS | 491 | Q8IYL2 | |
| LLTLKRPISGKTFLC | 211 | Q7RTZ1 | |
| RKLSLLLCSVPFVAG | 96 | Q9NY64 | |
| GPFLRKCFAISLLVI | 151 | O43490 | |
| CFLLGRLSIRKVKLS | 531 | Q8TF17 | |
| PKAVFVLSCLLKGRT | 71 | Q8WU76 | |
| TKSSRLAKPVLCLGT | 221 | Q8TBJ4 | |
| KLPLTPVFEGLAFKC | 1236 | Q12769 | |
| LEAGLAFTCKLKSPV | 791 | Q9UL12 | |
| LLFAKGAESSILPKC | 591 | Q9Y2G3 | |
| RNLVFLGISPKCVIK | 41 | Q08AN1 | |
| ICVSSFDGVFKLPKR | 66 | M0QZC1 | |
| CSRKRAFGVLKTLVP | 56 | O43511 | |
| CVILRTQKPKSSLLG | 541 | P50443 | |
| KVSFCLKRTVPTGDL | 91 | Q9BXM0 | |
| LLRCIKPQLKSFALG | 576 | Q9NYB5 | |
| GIAFCLNLIKTLKLP | 321 | Q8TCT8 | |
| TLKLPNFKSCVILLG | 331 | Q8TCT8 | |
| FVLATLLDPCFKGKI | 71 | Q96FA7 | |
| LARAKFISLITVKPC | 36 | Q2M238 | |
| VFLCLIRGVKSSGKV | 301 | P48067 | |
| QTAIKVSLKCPITFR | 591 | Q8NF64 | |
| CISVKEGIAIFLLRP | 496 | Q8NET8 | |
| IIPLVGCGFVSFRKK | 701 | Q7Z2W7 | |
| FRKQTPTKALCVLAS | 436 | Q8N584 | |
| VKRLSGICAQIIPFL | 81 | Q04725 | |
| VLRAFKVLRTLGSKC | 926 | O43156 | |
| SRFCKDVLPKLAGSL | 946 | O43156 | |
| ICFDSKPRIISKGTK | 556 | Q9UGR2 | |
| VKKIVSLVRSACSFP | 2201 | Q5VU43 |